.jpg)
.jpg)
.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The European Shortages Monitoring Platform (ESMP) is now live with the full scop...
EMA is celebrating 30 years of operations marking its evolving role at the centr...
EMA has recommended the approval of the vaccines Bluevac-3 and Syvazul BTV 3 to ...
FDA approved Symvess, the first acellular tissue engineered vessel for use in ad...
The FDA issued draft guidance that, when finalized, will provide recommendations...
The FDA issued draft guidance to provide recommendations on the use of artificia...
Today, the U.S. Food and Drug Administration issued draft guidance that includes...
The FDA published new draft guidance aimed at helping improve the accuracy and p...
The U.S. Food and Drug Administration is providing an at-a-glance summary of new...
Today, the U.S. Food and Drug Administration authorized the marketing of 20 ZYN ...
FDA issued a proposed rule that, if finalized, would make cigarettes and certain...
The U.S. Food and Drug Administration is providing an at-a-glance summary of new...
FDA announces a proposed rule requiring food manufacturers to display a front-of...
The U.S. Food and Drug Administration is providing an at-a-glance summary of new...
The FDA approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-cl...
The U.S. Food and Drug Administration is providing an at-a-glance summary of new...
TUESDAY, Feb. 4, 2025 -- For patients with BRAF V600E-mutant metastatic colorect...
TUESDAY, Feb. 4, 2025 -- Nystagmus during vertigo attacks in patients with Menie...
TUESDAY, Feb. 4, 2025 -- A transcutaneous electrical stimulation system (TESS) i...
TUESDAY, Feb. 4, 2025 -- Mental health disorders represent a significant problem...
TUESDAY, Feb. 4, 2025 -- Distant-stage prostate cancer increased and mortality r...
TUESDAY, Feb. 4, 2025 -- There are significant mental health disparities between...
TUESDAY, Feb. 4, 2025 -- Lifetime history of heavy cannabis use is associated wi...
TUESDAY, Feb. 4, 2025 -- The pooled prevalence of chronic painful neuropathy is ...